# The EPIVER Randomized Controlled Trial

> **NCT04573751** · NA · COMPLETED · sponsor: **Tomsk National Research Medical Center of the Russian Academy of Sciences** · enrollment: 104 (actual)

## Conditions studied

- ST Elevation Myocardial Infarction
- Percutaneous Coronary Intervention
- No-Reflow Phenomenon

## Interventions

- **DRUG:** Standard therapy
- **DRUG:** Epinephrine
- **DRUG:** Verapamil
- **DRUG:** Epinephrine + verapamil

## Key facts

- **NCT ID:** NCT04573751
- **Lead sponsor:** Tomsk National Research Medical Center of the Russian Academy of Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-30
- **Primary completion:** 2023-01-31
- **Final completion:** 2024-01-31
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2024-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04573751

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04573751, "The EPIVER Randomized Controlled Trial". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT04573751. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*